Anti‐inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia
- 1 December 2001
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 14 (12), 1961-1967
- https://doi.org/10.1046/j.0953-816x.2001.01820.x
Abstract
Advanced glycation endproducts (AGEs) accumulate on long-lived protein deposits including beta-amyloid plaques in Alzheimer's disease (AD). AGE-modified amyloid deposits contain oxidized and nitrated proteins as markers of a chronic neuroinflammatory condition and are surrounded by activated microglial and astroglial cells. We show in this study that AGEs increase nitric oxide production by induction of the inducible nitric oxide synthase (iNOS) on the mRNA and protein level in the murine microglial cell line N-11. Membrane permeable antioxidants including oestrogen derivatives (e.g. 17beta-oestradiol) thiol antioxidants (e.g. (R+)-alpha-lipoic acid) and Gingko biloba extract EGb 761, but not phosphodiesterase inhibitors such as propentophylline, prevent the up-regulation of AGE-induced iNOS expression and NO production. These results indicate that oxygen free radicals serve as second messengers in AGE-induced pro-inflammatory signal transduction pathways. As this pharmacological mechanism is not only relevant for Alzheimer's disease, but also for many chronic inflammatory conditions, such membrane-permeable antioxidants could be regarded not only as antioxidant, but also as potent therapeutic anti-inflammatory drugs.Keywords
This publication has 42 references indexed in Scilit:
- Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?Journal of Chemical Neuroanatomy, 2000
- Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial CellsBiochemical and Biophysical Research Communications, 1999
- High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expressionFEBS Letters, 1999
- Cytotoxicity of advanced glycation endproducts is mediated by oxidative stressJournal of Neural Transmission, 1998
- Role of Nuclear Factor- B Activation in Cytokine- and Sphingomyelinase-Stimulated Inducible Nitric Oxide Synthase Gene Expression in Vascular Smooth Muscle CellsEndocrinology, 1998
- Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative DiseasesThe American Journal of Pathology, 1998
- Redox regulation of cell functions by α‐lipoate: biochemical and molecular aspectsBioFactors, 1998
- Isoproterenol regulates tumour necrosis factor, interleukin‐10, interleukin‐6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemiaImmunology, 1997
- τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding DomainJournal of Neurochemistry, 1995
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990